Jianquan He, Xingxiang He, Yonghui Ma, Luxi Yang, Haiming Fang, Shu Shang, Huping Xia, Guanghui Lian, Hailing Tang, Qizhi Wang, Junping Wang, Zhihui Lin, Jianbo Wen, Yuedong Liu, Chunbao Zhai, Wen Wang, Xueliang Jiang, Ji Xuan, Morong Liu, Shiyun Lu, Xuejun Li, Han Wang, Cong Ouyang, Man Cao, Aiqiang Lin, Bangzhou Zhang, Depei Wu, Ye Chen, Chuanxing Xiao
BACKGROUND: Faecal microbiota transplantation (FMT) is an effective therapy for recurrent Clostridium difficile infections and chronic gastrointestional infections. However, the risks of FMT and the selection process of suitable donors remain insufficiently characterized. The eligibility rate for screening, underlying microbial basis, and core ethical issues of stool donors for FMT are yet to be elucidated in China. RESULTS: The potential stool donors were screened from December 2017 to December 2019 with the help of an online survey, clinical assessments, and stool and blood testing...
November 27, 2021: Microbial Cell Factories